TRAW icon

Traws Pharma
TRAW

Overview Fund Activity

27 hedge funds and large institutions have $1.26M invested in Traws Pharma in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
9
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$28.1K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$148K
3
UBS Group
3
UBS Group
Switzerland
$5.72K
4
VWWMG
4
Vermillion & White Wealth Management Group
Pennsylvania
$3.83K
5
Millennium Management
5
Millennium Management
New York
$11.5K

Top Sellers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$29.4K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$58.1K
4
TSS
4
Two Sigma Securities
New York
$0
5
Osaic Holdings
5
Osaic Holdings
Arizona
$3
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– – -30,713 Closed
TSS
27
Two Sigma Securities
New York
– – -10,929 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
29
Simplex Trading
Illinois
$0 107 – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 398 +191 +92%
1
2